Mutant mice with a heterozygous GSK-3β deletion showed decreased evidence of depression in the FST (23), and infusion of L803-mts, a selective GSK-3 inhibitor, also decreased immobility in the same test (24). This evidence concerns the gene GSK3B and major depressive disorder.